Jazz Pharmaceuticals (JAZZ) grants 1,605 restricted stock units to director

Rhea-AI Filing Summary

Hamill Laura reported acquisition or exercise transactions in this Form 4 filing.

Jazz Pharmaceuticals plc reported that director Laura Hamill received a grant of 1,605 restricted stock units, each representing one ordinary share, for no cash consideration. These units vest in full on July 23, 2027, subject to continuous service, bringing her direct holdings to 8,538 ordinary shares.

Insider Trade Summary

Net Buyer: 1,605 shares

Net Buy 1 txn

Insider Hamill Laura

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1	1,605	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 8,538 shares (Direct)

Footnotes (1)

1. F1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.

Key Figures

RSUs granted: 1,605 shares Grant price: 0.0000 per share Total direct holdings after grant: 8,538 shares +1 more

4 metrics

RSUs granted 1,605 shares Restricted stock units granted on 2026-08-05 to director Laura Hamill

Grant price 0.0000 per share Non-cash restricted stock unit award to a non-employee director

Total direct holdings after grant 8,538 shares Ordinary shares reported as directly owned following the award

RSU vesting date July 23, 2027 Restricted stock units vest in full on this date, subject to continuous service

Key Terms

restricted stock units, contingent right, continuous service, Non-Employee Directors Stock Award Plan

4 terms

restricted stock units financial

"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit."

continuous service financial

"Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."

Non-Employee Directors Stock Award Plan financial

"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/07/2026 - 05:51 PM Accepted by SEC EDGAR 08/07/2026 - 05:50 PM Learn about SEC filing dates

FAQ

What did Jazz Pharmaceuticals (JAZZ) disclose about Laura Hamill in this Form 4?

Jazz Pharmaceuticals reported that director Laura Hamill received a grant of 1,605 restricted stock units, each representing one ordinary share. The award was provided for no cash consideration under the company’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan.

How many Jazz Pharmaceuticals (JAZZ) shares did Laura Hamill receive, and at what cost?

Laura Hamill received 1,605 restricted stock units, with each unit representing a contingent right to one ordinary share. The Form 4 reports a grant price of 0.0000 per share, meaning the award was granted for no cash consideration as director equity compensation.

When do Laura Hamill’s Jazz Pharmaceuticals (JAZZ) restricted stock units vest?

The restricted stock units will vest in full on July 23, 2027. Vesting is conditioned on Laura Hamill’s continuous service with Jazz Pharmaceuticals and certain additional conditions described in the company’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan.

How many Jazz Pharmaceuticals (JAZZ) shares does Laura Hamill hold after this grant?

Following the reported award, Laura Hamill is shown as directly holding 8,538 ordinary shares of Jazz Pharmaceuticals. This post-transaction figure includes the shares associated with the newly granted restricted stock units as they are reported in the non-derivative holdings table.

Was Laura Hamill’s Jazz Pharmaceuticals (JAZZ) equity award made under a Rule 10b5-1 plan?

No. The Form 4’s Rule 10b5-1 checkbox is not checked, indicating the transaction was not reported as made under a Rule 10b5-1 trading plan. Instead, the footnote describes the grant under the company’s Non-Employee Directors Stock Award Plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hamill Laura

(Last) (First) (Middle)

5TH FL, WATERLOO EXCHANGE

WATERLOO RD

(Street)

DUBLIN 4

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/05/2026		A(1)		1,605	A	$0.0	8,538	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.

	By: /s/Paz Dizon, as attorney in fact For: Laura Jean Hamill	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)